VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LLY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LLYEli Lilly and Company
$1206.51$1.14T
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLLYQuarterly Financials

Eli Lilly and Company (LLY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Eli Lilly and Company (LLY) quarterly income statement — complete revenue, gross profit & net income history

LLY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue19.8B19.29B17.6B15.56B12.73B13.53B11.44B11.3B8.77B9.35B9.5B8.31B
Revenue Growth %55.55%42.56%53.87%37.64%45.17%44.68%20.43%35.98%25.98%28.1%36.84%28.12%
Cost of Goods Sold3.58B2.88B3.01B2.45B2.22B2.4B2.17B2.17B1.67B1.79B1.86B1.81B
COGS % of Revenue18.07%14.95%17.09%15.73%17.47%17.76%18.98%19.2%19.09%19.12%19.58%21.74%
Gross Profit16.22B16.41B14.59B13.11B10.5B11.13B9.27B9.13B7.09B7.57B7.64B6.5B
Gross Margin %81.93%85.05%82.91%84.27%82.53%82.24%81.02%80.8%80.91%80.88%80.42%78.26%
Gross Profit Growth %54.43%47.44%57.45%43.55%48.06%47.1%21.34%40.4%33.02%31.49%42.44%28.61%
Operating Expenses7.37B7.63B6.21B5.98B5.1B5.33B4.72B4.71B4.36B4.37B4.1B4.17B
OpEx % of Revenue37.23%39.57%35.26%38.46%40.04%39.39%41.25%41.71%49.71%46.75%43.14%50.12%
Selling, General & Admin2.93B3.34B2.74B2.65B2.36B2.31B1.98B2B1.84B1.81B1.69B1.81B
SG&A % of Revenue14.82%17.33%15.57%17.02%18.56%17.06%17.35%17.72%20.94%19.35%17.78%21.77%
Research & Development3.51B3.8B3.47B3.34B2.73B3.02B2.73B2.71B2.52B2.56B2.41B2.36B
R&D % of Revenue17.73%19.71%19.69%21.44%21.48%22.33%23.9%23.99%28.77%27.4%25.36%28.35%
Other Operating Expenses1000K1000K0000000000
Operating Income8.85B8.78B8.39B7.13B5.41B5.8B4.55B4.42B2.74B3.19B3.54B2.34B
Operating Margin %44.7%45.49%47.65%45.8%42.49%42.84%39.77%39.09%31.2%34.14%37.28%28.13%
Operating Income Growth %63.63%51.36%84.32%61.28%97.7%81.57%28.49%88.95%59.53%44.65%73.77%34.02%
EBITDA9.36B8.93B8.86B7.6B5.87B6.28B5.02B4.83B3.14B3.58B3.95B2.7B
EBITDA Margin %47.27%46.28%50.32%48.88%46.13%46.42%43.85%42.76%35.77%38.28%41.61%32.54%
EBITDA Growth %59.41%42.1%76.54%57.35%87.21%75.45%26.94%78.69%50.99%38.66%64.62%29.18%
D&A (Non-Cash Add-back)509M152.2M470M478.5M462.8M484.8M466.8M414.4M400.6M387.7M411M366.3M
EBIT8.85B8.24B7.41B7.03B3.7B5.26B1.78B3.7B2.72B2.65B551.8M2.21B
Net Interest Income-332M-123M-114.6M-209M-195.4M-180.4M-144.9M-146.3M-133.8M-93.7M-75.7M-74.3M
Interest Income0065M40M48.3M44.3M47.8M37.3M45.8M44.5M48.9M46M
Interest Expense332M123M179.6M249M243.7M224.7M192.7M183.6M179.6M138.2M124.6M120.3M
Other Income/Expense0-509.2M-1.15B-349.8M-1.95B-759.1M-2.96B-901.3M-199.5M-684.3M-3.11B-249.5M
Pretax Income8.85B8.27B7.23B6.78B3.46B5.04B1.59B3.52B2.54B2.51B427.2M2.09B
Pretax Margin %44.7%42.84%41.09%43.56%27.15%37.23%13.89%31.12%28.92%26.82%4.5%25.13%
Income Tax1.45B1.63B1.65B1.12B696.8M628.9M618.1M550.2M293.2M319.1M484.6M325.7M
Effective Tax Rate %16.43%19.71%22.81%16.47%20.16%12.48%38.91%15.64%11.56%12.72%113.44%15.59%
Net Income7.4B6.64B5.58B5.66B2.76B4.41B970.3M2.97B2.24B2.19B-57.4M1.76B
Net Margin %37.36%34.4%31.72%36.38%21.68%32.59%8.48%26.25%25.58%23.41%-0.6%21.21%
Net Income Growth %168.04%50.48%475.34%90.78%23.02%101.39%1790.42%68.27%66.77%13.01%-103.95%85.11%
Net Income (Continuing)7.4B6.64B5.58B5.66B2.76B4.41B970.3M2.97B2.24B2.19B-57.4M1.76B
Discontinued Operations000000000000
Minority Interest0057.5M76.2M82M79.5M80.7M73.5M85.2M91.8M87M85.5M
EPS (Diluted)8.267.396.216.293.064.881.073.282.482.42-0.061.86
EPS Growth %169.93%51.43%480.37%91.77%23.39%101.65%1868.59%76.34%74.65%18.63%-103.76%77.14%
EPS (Basic)8.277.416.226.303.074.911.083.292.492.43-0.061.86
Diluted Shares Outstanding895.9M898M898.8M899.79M900.6M903.16M905M904.2M903.8M903.98M949.3M949.29M
Basic Shares Outstanding894.5M898M896.9M897.9M897.99M897.54M901M900.9M900.8M899.38M949.3M949.29M
Dividend Payout Ratio20.93%20.28%24.1%23.8%48.79%26.49%120.63%39.51%52.13%46.49%-57.72%